Medical Niobium Hafnium Alloy C103 Foil

Shaanxi Zhongheng Weichuang Metal Materials Co., Ltd. supplies high-quality rare metals, mainly including niobium hafnium alloy 103, tungsten, tantalum, niobium, hafnium, titanium, zirconium, nickel, vanadium and alloys of conventional processed profiles such as plates, strips, coils, rods, wires, pipes, as well as deep processed products such as ships, crucibles, sputtering targets, coating targets, machined parts, high-temperature furnace insulation screens, heating elements, furnace bodies (heating furnaces, annealing furnaces), corrosion-resistant equipment, etc.

As a manufacturer, supplier, and exporter of c103, we provide high-purity, high-temperature resistant, aerospace, defense, military, and marine engineering specialized products with worry free quality and more favorable prices! Customer service is always online, so you have no worries.
 

C103 niobium hafnium alloy (containing 40% -60% niobium and 10% -30% hafnium) can be made into foil with a thickness of 0.01-0.1mm through precision rolling technology. Its biocompatibility comes from the stable passivation oxide layer on the surface, which can effectively suppress the release of metal ions. Experiments have shown that the corrosion rate of this material in simulated body fluids is less than 0.001mm/year, and its cytotoxicity rating is level 0 under ISO 10993-5 standard (no cytotoxicity). Its elastic modulus (about 50GPa) is closer to human bones and can significantly reduce stress shielding effects.

Typical Medical Application Cases

• Orthopedic implants

The C103 alloy femoral head prosthesis developed by Suzhou Minimally Invasive Medical is made into a porous structure through 3D printing technology to promote bone tissue growth. Clinical tests have shown that after 6 months of surgery, the bone integration rate increased by 27% compared to titanium alloy, and the wear rate decreased to 0.12mm/year.

• Cardiovascular stent

Tomsk University of Technology in Russia used C103 foil to prepare a vascular stent, which was anodized to generate a nanotube array that could be loaded with anticoagulant drugs. Animal experiments have confirmed that its drug release cycle is 28 days, and its restenosis rate is 41% lower than traditional stents.

• Dental restoration

The C103 alloy dental crown substrate developed by a German company achieves micrometer level accuracy through electron beam melting technology. Comparative studies have shown that its edge adhesion reaches 92 μ m, which is superior to cobalt chromium alloy (165 μ m).

The current medical application of C103 foil still faces two major bottlenecks: firstly, the high-temperature forming process is prone to hafnium element segregation, which affects the uniformity of the material; Secondly, the surface functionalization modification technology is not yet mature. In the future, breakthroughs can be made through the following paths:

• Additive Manufacturing Optimization: Using Selective Laser Melting (SLM) technology, the powder particle size is controlled within the range of 15-45 μ m, increasing the density to over 99.2%.
• Intelligent coating development: Drawing on SiC coating technology used in the nuclear industry, hydroxyapatite composite coatings have been developed in the medical field to enhance antibacterial performance by 5 times.

With the intensification of global aging, the orthopedic implant market is expected to have a compound annual growth rate of 8.7% from 2025 to 2030. C103 niobium hafnium alloy foil material, with its unique mechanical biological coupling characteristics, is expected to achieve breakthroughs in the following fields:

• Degradable implants: By adjusting the hafnium content to 15% -20%, develop a degradation cycle with controllable mechanical properties (6-24 months).
• Neural interface material: Utilizing its superconducting properties (critical temperature of 9.2K), develop high-sensitivity brain computer interface electrodes.
• Targeted medical carriers: Combining nanotube structures to achieve precise delivery of anti-cancer drugs, the related market size is expected to exceed $12 billion by 2030.

In 2025, cross-border healthcare has become a new trend in the industry, with giants such as Midea and Huawei accelerating their layout in the medical device field, providing a broader platform for the application of C103 alloy foil materials. For example, Huawei's 5G technology can enable real-time data transmission of remote surgical instruments, and the high-precision characteristics of C103 alloy are in line with the strict requirements of intelligent medical devices for material performance. In the future, through the deep integration of "materials technology scenes", this material may become one of the core driving forces for the upgrading of the medical and health industry

Hot Tags: medical niobium hafnium alloy c103 foil, China medical niobium hafnium alloy c103 foil manufacturers, suppliers, factory